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additional epidemiological studies can
elucidate this issue. Future research
should be aimed at understanding the
natural history of cutaneous HPV,
including the antibody response to
infection and the mechanism by which
HPV transforms keratinocytes. In
addition, future studies should extend
the analysis beyond the presence of
viral DNA in tissue to assess viral
gene or protein expression. Finally,
researchers need to address the
alternate hypothesis that HPV carriage
on the skin is merely a reflection of local
immune surveillance and not a specific
oncoviral etiological agent for NMSC.
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What Lies Beneath? Scanning Probe
Tomography May Have the Answer
Michael J. Conneely1 and Paul A. Campbell1
Scanning probe microscopy facilitates high-resolution noninvasive imaging
of surface topography on even the most delicate of biological structures.
Moreover, the local probe nature of the instrument architecture lends itself to
the measurement of many important physical properties. To date, biological
investigations have largely been constrained to imaging surface (membrane)-
borne phenomena; however, the advent of extremely high aspect-ratio ‘needle’
probe tips, as reported by Beard et al. (2013), suggests that the approach can now
be extended to address the particular challenges associated with measuring
subsurface microscopic targets, including the intracellular components of the
stratum corneum.
Journal of Investigative Dermatology (2013) 133, 1458–1460. doi:10.1038/jid.2013.30
Scanning probe microscopy (SPM)
emerged, in a spectacular manner,
from IBM’s Zurich Laboratory during
the 1980s. The technology boasted of
a capability to generate topographic
images of metal and semiconductor
surfaces with atomic resolution and
promptly won its inventors, Heinrich
Rohrer and Gerd Binnig, a Nobel Prize
for Physics a scant 5 years after
their initial invention (Binnig and
Rohrer, 1987). SPM has since reached
a state of some maturity during which
its versatility has been extended
considerably, most notably to include
electrically insulating samples—thus
opening the way for its exploitation
within the field of life sciences. The
most prevalent modern incarnation
of SPM, atomic force microscopy
(AFM), works by electronically scanning
a microscopically sharp (usually Si
or Si3N4) tip over a sample surface
under feedback control—simultaneously
monitoring the variation in forces arising
and automatically correcting for that in
order to generate a map of the sample’s
3-D topography. As a passive imaging
modality, AFM thus offers an impressive
capability to break through the conven-
tional optical diffraction limit and
achieve molecular-level resolution on
membrane structures under clinically
relevant physiological conditions.
This latter point has not been lost on
the dermatology community. Indeed,
the first paper using an AFM and
reported in this journal was published
as far back as July 1995, when the
group of John Baldeschwieler at the
California Institute of Technology used
AFM to quantitatively monitor, in real
time, the morphological changes occur-
ring upon the hair cuticle as a function
of environmental conditions (O’Connor
et al., 1995). However, AFM offers
much more than a noninvasive imaging
modality. The controllable interaction
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of probe tip with sample facilitates
simultaneous recording of topographi-
cal information together with that of
local (spatiotemporal) mechanical
properties. Flexibility in the commercial
availability of different probe tips,
combined with this capacity to exert
and measure local forces, facilitates the
extraction of (often critical) information
relating to local elasticity, adhesiveness,
and frictional properties. Indeed, recent
studies of direct interest to this reader-
ship by Bhushan (2012) and Dulinska-
Molak et al. (2012) have, respectively,
focused on measuring/analyzing the tri-
bological and nano-mechanical proper-
ties of skin (including synthetic options)
and corneocytes in the presence of an
extensive range of topical preparations.
The general procedure for extracting
quantitative nano-mechanical data with
AFM involves the recording of ‘‘force–
distance’’ curves, which are simply
graphs of the tip-surface interaction
force as a function of the tip displace-
ment from the sample surface. It is
noteworthy that this method of mechan-
ical probing has application potential
across the wider biological sciences, as
typified by its utility for discriminating
benign from malignant cells (Plodinec
et al., 2012) and in assessing the
biophysical response of cells to
physical (ultrasonic) stimulus (Conneely
et al., 2012), as well as serving as a
candidate rapid-screening method for
the development of new skin-care
products (Gaikwad et al., 2010).
In order to support our understanding
of experimentally measured force–
distance curves, and to extract mean-
ingful quantitative data, judicious selec-
tion of a physical model is required,
with due consideration for the bulk
physical properties of the sample
material. Fortunately, however, such
options are usually available within the
software-based analysis environment of
modern SPM systems. Importantly, mod-
els are sensitive to the geometry and
stiffness of the probe tip under consid-
eration, as highlighted in the presently
featured work (Beard, 2011; Beard
et al., 2013), and thus access to some
means of in-house characterization,
such as electron microscopy, will be
desirable for potential users who choose
not to take manufacturer specifications
at face value. That said, the commercial
AFM probe market includes a range of
tip morphologies that have often
been precharacterized in this manner,
so that direct exploitation within such
specialized metrological endeavors
becomes feasible. One such example
at present relates to ‘force-mapping’—
the acquisition of multiple force–
distance curves at gridded reference
points across the sample, in order to
generate a (spatiotemporal) map of local
elasticity. This concept has also
been extended to achieve the so-called
‘stiffness tomography’ (Roduit et al.,
2009), whereby subsurface inclusions
that exhibit different physical properties
compared with the surrounding bulk
material can be discriminated. Progress
here has, however, been constrained by
the low aspect-ratio nature of regular
AFM tips, which do not lend them-
selves to deep noninvasive penetration
into cells without compromising the
integrity of the sample itself.
In addressing this issue, Beard et al.
(2013) have introduced an innovative
high aspect-ratio probe tip structure,
the so called ‘nano-needle’, featuring a
narrow finger of electron beam–
deposited amorphous carbon. These
nanostructures typically exhibit a
cylindrical geometry with dimensions
in the order of 500 nm in length and
radii of curvature at the hemispherical
ends lying within the range of 30–80 nm
(as determined by electron microscopy).
The most immediate advantage offered
by these relatively long and thin nanos-
tructured probes is the ability to pass
through the membrane, during the con-
tact/indentation stage, and enter the
cellular interior without significant
structural damage, or perturbation to
cellular function and viability. Beard
et al. (2013) evaluated the forces
occurring on such nano-needles during
the insertion/retraction phases by using
a refined computational model, which
in effect elucidated the depth-dependent
local stiffness over the full penetration
length of the nano-needle. Moreover,
bonus information becomes available
relating to the elastic recovery of the
cell after retraction of the nano-needle
probe. An important and ultimately
compelling point of note is that their
interpretation of the data also correlates
with the known structural characteristics
of corneocytes: namely, that the ‘two-
layer’ model pertaining to the signature
force curves (viz Fig. 4 in Beard et al.
(2013)) corresponds to a relatively
soft external lipid-protein envelope,
estimated to have an elasticity modulus
of 100 MPa, surrounding a much stiffer
(approximately 500 MPa), internal
matrix of keratin filament bundles.
It would seem, therefore, that the
introduction of nanostructured ‘needle’
probes effectively enhances the informa-
tion-gathering potential of AFM, elevat-
ing it from a merely two-dimensional
surface sensing technology to a fully
three-dimensional new form of nano-
mechanical tomography. What immedi-
ate strategy might then serve to advance
the technique? An obvious platform
for new experiments must embrace the
present lack of structural knowledge
within the nano-indented sample, in a
noninvasive way. By integrating with
inverted light microscopy, particularly
with a confocal capability as in the
study conducted by Pesen and Hoh
(2005), the actual force measurements
obtained during penetration of a
nano-needle probe could be related
to the presence of specific subcellular
features. Calibration of this tomographic
Clinical Implications
 Scanning probe microscopy allows simultaneous noninvasive imaging and
measurement of mechanical properties in materials.
 Surface or subsurface topography measurements of skin or hair shafts can
be combined with measurements of elasticity, tensile strength, or other
functional properties.
 ‘‘Nano-needles’’ allow probes to enter cells without significant damage
and thus obtain intracellular in vivo measurements.
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approach using embedded materials
with well-defined elastic moduli,
and at controlled depths within a
phantom matrix, must also be under-
taken. Furthermore, the experimental
measurements must be used to validate
computational models of these same
scenarios, as in the study conducted
by Roduit et al. (2009). When such
data are forthcoming and a platform of
confidence in the approach has been
firmly established, then the pursuit of
more intricate relationships, such
as the depth dependence of filaggrin
degradation suggested by Beard et al.
(2013), ought to be possible. By
undertaking parallel electrophysiology
on targeted structures during the nano-
indentation process, perhaps by the
implementation of recent microfabri-
cation innovations for intra-cellular
recording (Duan et al., 2011), a real-
time assessment of membrane trafficking
can also be undertaken during the critical
bulk penetration stage, which will
inform on downstream viability profiles.
The emergence of the new tomo-
graphy technique is also rather timely:
researchers will not have to go through
the trouble and expense involved in
generating their own ‘nano-needle’ tips,
as commercially available entities have
already emerged (viz NaugaNeedles.com
or www.Nanotools.com for example). It
would thus seem that the only short-term
limitation with local probe tomography
will rest in the collective imagination of
its first wave of users.
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Circulating Melanoma Cells as a
Predictive Biomarker
Giorgos Karakousis1, Ruifeng Yang2 and Xiaowei Xu2
The prognosis of patients with metastatic melanoma has improved significantly
with targeted therapeutic agents and immunotherapies. Detection of early
melanoma recurrence after treatment will be beneficial to switch patients who
fail on one therapy to different modalities. Circulating tumor cells (CTCs) are
cancer cells released by a tumor into the peripheral blood. These cells hold
potential as prognostic, predictive, and pharmacodynamic biomarkers for treat-
ment. In this issue, Khoja et al. report that melanoma CTCs can be detected using
Melcam and high molecular weight melanoma–associated antibody. They found
that in 101 stage IV melanoma patients, CTC numbers ranged between 0 and 36/
7.5ml blood; 26% of the patients hadX2 CTCs at baseline. The CTC number (X2
CTCs) at baseline was significantly prognostic for median overall survival (OS) in
univariate and multivariate analysis. Patients receiving treatment where CTC
numbers remained X2 CTCs during their treatment had shorter median OS than
those who maintained o2 CTCs (7 vs. 10 months, hazard ratio 0.34, 95%
confidence interval 0.14–0.81, log-rank test P¼ 0.015). The implications of this
work are substantial in counseling patients about their prognosis and in helping to
assess responses to systemic therapies.
Journal of Investigative Dermatology (2013) 133, 1460–1462. doi:10.1038/jid.2013.34
Targeted therapies such as the mutant
BRAF selective inhibitors vemurafenib
and dabrafenib have improved the sur-
vival of patients with metastatic mela-
noma (Flaherty et al., 2010, 2012a,b;
Sosman et al., 2012). However,
subsequent drug resistance and disease
progression has been observed in most
of the treated patients (Flaherty, 2012).
Anti-CTLA4 and anti-PD1 immuno-
therapies have also improved overall
survival (OS) in metastatic melanoma
patients, with a subset of patients having
long-term survival (Hodi et al., 2010;
Lipson et al., 2013). With effective
therapies of this sort, it has become
important to monitor patients and to
identify early signs of treatment failure.
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